GILD vs RMNI · P/E 18, rev $7.80B vs P/E 12, rev $216.5M
Gilead Sciences Inc (GILD) versus Rimini Street Inc (RMNI) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Rimini Street Inc (RMNI) is a software - application company listed on NASDAQ.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported RMNI revenue for 2026-06-30 was $216.5M. Net income was $3.8M. RMNI currently screens at market cap $385.5M and trailing P/E 11.6.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. RMNI currently screens at market cap $385.5M and trailing P/E 11.6.
Not investment advice. Open the GILD and RMNI stock pages for the full models.
Not investment advice.